within the quickly evolving discipline of oncology investigate, correct and productive mutation screening is critical for acquiring focused therapies. The KRAS Services Platform plays a pivotal job On this landscape by providing comprehensive methods for KRAS mutation profiling and analysis. KRAS mutations, present in somewhere around ninety five%